Biomarkers · Chemical
INR
- LOINC codes
- 6301-6
- Tests that measure INR
- Labcorp 7
Tests
Check the catalog code, specimen, method and preparation for every test that measures INR. Select up to five tests to compare them side by side.
Labcorp 7 tests
Panels that include this biomarker
Prothrombin Time (PT) 005199
2 analytes · Plasma · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- Prothrombin time reagent containing thromboplastin and calcium chloride is mixed with the patient plasma and the time to clot formation is measured photo-optically. The calcium chloride overcomes the citrate anticoagulant and allows the tissue factor in the thromboplastin to initiate coagulation. The prolongation of the clotting time correlates with the degree of deficiency or inhibition of the extrinsic pathway factors.
- Collection
- Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate.1 Evacuated collection tubes must be filled to completion to ensure a proper blood-to-anticoagulant ratio.2,3 The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples unless the sample is collected using a winged (butterfly) collection system. With a winged blood collection set a discard tube should be drawn first to account for the dead space of the tubing and prevent under-filling of the evacuated tube.4,5 When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternative anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. Please print and use the Volume Guide for Coagulation Testing to ensure proper draw volume.
- Reference notes
- See table. Age | Range13-15 Prothrombin Time (PT) 1 day | 14.4−16.4 sec 3 days | 13.5−16.4 sec 1 to 11 m | 11.5−15.3 sec 1 to 5 y | 12.1–14.5 sec 6 to 10 y | 11.7−15.1 sec 11 to 16 y | 12.7−16.1 sec >16 y | 12.2 –14.9 sec International Normalized Ratio (INR) 0 to 1 m | 0.9−1.4 >1 m | 0.9−1.2
Prothrombin Time (PT) (Serial Monitor) 485199
2 analytes · Specimen not stated · Fasting not stated · Turnaround Within 1 day
Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) 020321
3 analytes · Plasma · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Preparation
- Draw specimen one hour before next dose of heparin if heparin is being given by intermittent injection. Do not draw from an arm with a heparin lock or heparinized catheter.
- Collection
- Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate.1 Evacuated collection tubes must be filled to completion to ensure a proper blood to anticoagulant ratio.2,3 The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples.4,5 When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternate anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested. Please print and use the Volume Guide for Coagulation Testing to ensure proper draw volume.
- Reference notes
- See table. Age | Range6-8 Activated Partial Thromboplastin Time (aPTT) 1 d | 29–38 sec 3 d | 25−36 sec 1 to 11 m | 30−39 sec 1 to 5 y | 29−37 sec 6 to 10 y | 27–37 sec 11 to 16 y | 25–34 sec >16y | 23–34 sec Prothrombin Time (PT) 1 d | 14.4−16.4 sec 3 d | 13.5−16.4 sec 1 to 11 m | 11.5−15.3 sec 1 to 5 y | 12.1–14.5 sec 6 to 10 y | 11.7−15.1 sec 11 to 16 y | 12.7–16.1 sec >16y | 12.2–14.9 sec International Normalized Ratio (INR) 0 to 1 m | 0.9−1.4 >1 m | 0.9−1.2
Abnormal Bleeding Profile 116004
4 analytes · Plasma · Fasting not stated · Turnaround 2 - 3 days
Labcorp catalog pageMethod and collection
- Method
- See individual tests.
- Preparation
- Ideally, the patient should not be on anticoagulant therapy. Avoid warfarin (Coumadin®) therapy for two weeks prior to the test and heparin, direct Xa, and thrombin inhibitor therapies for about three days prior to testing.
- Collection
- Citrated plasma samples should be collected by double centrifugation. Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate.1 Evacuated collection tubes must be filled to completion to ensure a proper blood to anticoagulant ratio.2,3 The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples, except when using a winged blood collection device (ie, "butterfly"), in which case a discard tube should be used.4,5 When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternate anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. Centrifuge for 10 minutes and carefully remove 2/3 of the plasma using a plastic transfer pipette, being careful not to disturb the cells. Deliver to a plastic transport tube, cap, and recentrifuge for 10 minutes. Use a second plastic pipette to remove the plasma, staying clear of the platelets at the bottom of the tube. Transfer the plasma into a Labcorp PP transpak frozen purple tube with screw cap (Labcorp No. 49482). Freeze immediately and maintain frozen until tested. Please print and use the Volume Guide for Coagulation Testing to ensure proper draw volume.
Drug-Induced Liver Injury Profile 010045
6 analytes · Serum · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- See individual tests.
- Collection
- Serum or plasma: Separate serum or plasma from cells within 45 minutes of collection. PT with INR blood: Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate. Evacuated collection tubes must be filled to completion to ensure a proper blood-to-anticoagulant ratio. The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples unless the sample is collected using a winged (butterfly) collection system. With a winged blood collection set a discard tube should be drawn first to account for the dead space of the tubing and prevent under-filling of the evacuated tube. When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternative anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. Print and use the Volume Guide for Coagulation Testing to ensure proper draw volume.
0 of 5 tests selected
Pick one moreSources
Check the guidelines, studies and lab catalogs behind every range and link on this page. Open a source to see each claim it backs.
Lab catalogs
Labcorp test menu
Labcorp
Test catalog: 7 tests, with codes, specimens, methods and reference intervals
Codes and registries
LOINC 6301-6
Regenstrief Institute codes that identify the same result across labs.
Search ClinicalTrials.gov for INR
Registered studies that measure INR, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.